OncoCyte Corporation
OCX
$2.73
$0.083.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 456.27% | -8.44% | -76.36% | -48.28% | -54.86% |
| Total Receivables | 2,098.76% | 233.26% | -88.89% | -95.05% | -91.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 68.03% | 27.68% | -6.70% | -49.53% | -24.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 100.72% | 160.43% | -83.25% | -85.51% |
| Total Current Assets | 454.90% | 9.92% | -71.67% | -52.50% | -58.24% |
|
|
|||||
| Total Current Assets | 454.90% | 9.92% | -71.67% | -52.50% | -58.24% |
| Net Property, Plant & Equipment | 24.93% | 16.34% | 11.35% | -24.72% | -32.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -74.19% | -74.19% | -0.16% | -0.16% | -0.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.54% | 10.54% | 8.06% | 11.53% | 3.43% |
| Total Assets | -14.95% | -53.16% | -13.94% | -14.64% | -14.28% |
|
|
|||||
| Total Accounts Payable | 150.99% | 139.14% | -23.24% | 20.11% | -34.91% |
| Total Accrued Expenses | 29.95% | 7.96% | 9.36% | -19.82% | -6.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 71.01% | 94.74% | 78.19% | 39.62% | 5.94% |
| Total Finance Division Other Current Liabilities | -81.29% | -90.33% | 16.51% | -9.54% | -12.97% |
| Total Other Current Liabilities | -81.29% | -90.33% | 16.51% | -9.54% | -12.97% |
| Total Current Liabilities | 16.28% | 1.13% | 13.16% | -6.12% | -11.70% |
|
|
|||||
| Total Current Liabilities | 16.28% | 1.13% | 13.16% | -6.12% | -11.70% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.50% | 7.49% | 15.04% | 10.01% | -1.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.17% | -5.49% | 69.62% | 44.70% | 57.97% |
| Total Liabilities | -7.24% | -3.94% | 54.74% | 32.65% | 37.42% |
|
|
|||||
| Common Stock & APIC | 18.30% | 9.01% | 5.38% | 5.38% | 5.08% |
| Retained Earnings | -19.47% | -20.93% | -16.36% | -14.12% | -16.05% |
| Treasury Stock & Other | 2.50% | -57.14% | 78.13% | -9.76% | -6.98% |
| Total Common Equity | -11.82% | -159.97% | -74.15% | -47.93% | -69.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -3.62% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -3.62% |
|
|
|||||
| Total Common Equity | -11.82% | -159.97% | -74.15% | -47.93% | -69.45% |
| Total Preferred Equity | -- | -- | -- | -- | -3.62% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.61% | -147.96% | -77.14% | -53.02% | -61.07% |
|
|
|||||